Richard Harris

Richard Harris appears in the following:

Doctors Deploy Antibody Drugs Against COVID-19 And Hope Effort's Worthwhile

Wednesday, November 25, 2020

The medicines from Eli Lilly and Regeneron are infused, a process that can take two hours or longer, including observation for side effects. Staffing is as big an issue as the supply of the drugs.

Comment

Hospitals Puzzled With How To Administer Monoclonal Antibodies To COVID-19 Patients

Wednesday, November 25, 2020

Hospitals are figuring out how to administer drugs that are designed to treat people with mild to moderate COVID-19 symptoms. The drugs are in short supply, and there is no guarantee they will work.

Comment

A Look At COVID-19 Vaccine Development Progress

Saturday, November 21, 2020

The race to develop COVID-19 vaccines is moving swiftly, both nationally and internationally. But challenges remain when it comes to distributing vaccines around the world.

Comment

A New COVID-19 Treatment Is Coming, But There's A Catch

Saturday, November 21, 2020

A new medication to treat COVID patients will be available next week, but it requires an IV and is in short supply.

Comment

Pandemic Update: Coronavirus Case Numbers And Latest On A Vaccine

Monday, November 16, 2020

As coronavirus cases surge across the United States, a second vaccine candidate is said to show great promise. Experts say the first vaccines could become available as early as late December.

Comment

FDA OKs Eli Lilly COVID-19 Drug, But Supplies Will Be Limited

Tuesday, November 10, 2020

Eli Lilly's monoclonal antibody will be available to people 65 or older or those with underlying health conditions. Supplies will be short, and allocating the medicine will be a challenge.

Comment

Government Signs Deal For COVID-19 Treatments From Eli Lilly

Wednesday, October 28, 2020

The federal government plans to distribute 300,000 doses of the drug at no cost, but that doesn't mean treatment will be free. Intravenous infusion charges can run more than $1,000.

Comment

How Will The Limited Supply Of Antibody Drugs For COVID-19 Be Allocated?

Wednesday, October 21, 2020

Experimental medicines have the potential to help people with COVID-19 avoid hospitalization. The scarce supply of the treatments would have to be rationed, if regulators OK their use.

Comment

How Will The U.S. Distribute COVID-19 Antibody Drugs If They Get FDA Approval?

Wednesday, October 21, 2020

COVID-19 antibody drugs appear to be helping people avoid hospitalization. Tens of thousands of people a day could be candidates to take the drugs, but the scarce supply has to be rationed.

Comment

Update On Coronavirus Vaccine And Drugs

Friday, October 16, 2020

Pfizer announced Friday there would be no coronavirus vaccine before the election. And a new study questioned the effectiveness of remdesivir, a drug used to treat hospitalized COVID-19 patients.

Comment

Pfizer COVID-19 Vaccine Won't Be Ready By Election Day

Friday, October 16, 2020

Pfizer Chairman and CEO Albert Bourla said in a public statement Friday that the company won't have data showing that the vaccine is safe before the third week of November at the earliest.

Comment

Johnson & Johnson, Eli Lilly Pause COVID-19 Drug Trials

Tuesday, October 13, 2020

The move by Eli Lilly came less than 24 hours after Johnson & Johnson paused further dosing in all of its COVID-19 vaccine candidate clinical trials while it investigated a volunteer's illness.

Comment

Trump Touts Antibody Treatments For COVID-19, But Evidence Is Incomplete

Thursday, October 08, 2020

Medical researchers have high hopes that the kind of treatment the president received could end up being an important element in the fight against the pandemic. But clinical trials continue.

Comment

Could COVID-19 Be Treated By Drug Trump Is Touting?

Thursday, October 08, 2020

President Trump continues to tout an experimental treatment he received for COVID-19. NPR discusses if the drug is safe and whether there is enough of it to distribute across the U.S.

Comment

Update On Trump's Medical Status

Tuesday, October 06, 2020

NPR discusses the latest on President Trump's health, his treatment for COVID-19 and his misleading statements on social media downplaying the lethality of the illness.

Comment

Trump Says He'll Return To The White House Soon. Is It Safe?

Monday, October 05, 2020

Lots of questions remain about President Trump's condition. NPR discusses his health and medical treatment and what would be the best safety protocols for the White House to follow.

Comment

Physician Clarifies Contradictory Statements But Maintains Trump Is 'Doing Well'

Sunday, October 04, 2020

President Trump is hospitalized and is being treated with experimental therapies less than a month from Election Day. There was a briefing on his condition Sunday.

Comment

Advances In ICU Care Are Saving More Patients Who Have COVID-19

Sunday, September 20, 2020

One thing that has improved a lot over the course of the pandemic is treatment of seriously ill COVID-19 patients in intensive care units. Here's one man's success story.

Comment

Experimental Medicines For COVID-19 Could Help Someday, But Home Runs Not Guaranteed

Friday, September 18, 2020

Drugs are being tested that could reduce symptoms and save lives. But, given the way drugs are developed, it's unlikely that any single medicine will be anywhere as potent as a successful vaccine.

Comment

COVID-19 Medications Are In Development, But A True Cure Would Likely Take Years

Friday, September 18, 2020

Most drugs don't actually cure diseases. They can help ease symptoms and up the odds of survival. This will likely be true for COVID-19 drugs. A true cure would likely take years to develop.

Comment